The stock of Medtronic Plc (MDT) has seen a -2.98% decrease in the past week, with a -4.72% drop in the past month, and a -7.73% decrease in the past quarter. The volatility ratio for the week is 1.24%, and the volatility levels for the past 30 days are at 1.60% for MDT. The simple moving average for the last 20 days is -2.35% for MDT stock, with a simple moving average of -0.61% for the last 200 days.
Is It Worth Investing in Medtronic Plc (NYSE: MDT) Right Now?
Medtronic Plc (NYSE: MDT) has a price-to-earnings ratio that is above its average at 25.62x. The stock has a 36-month beta value of 0.83. Opinions on the stock are mixed, with 11 analysts rating it as a “buy,” 6 as “overweight,” 14 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MDT is 1.28B, and at present, short sellers hold a 0.93% of that float. On December 10, 2024, the average trading volume of MDT was 6.15M shares.
MDT) stock’s latest price update
Medtronic Plc (NYSE: MDT) has seen a decline in its stock price by -0.06 in relation to its previous close of 84.01. However, the company has experienced a -2.98% decline in its stock price over the last five trading sessions. fool.com reported 2024-12-07 that Investors looking for stocks to hold on to for a while might want to consider dividend-paying companies. Besides offering a regular stream of passive income, dividend stocks have generally outperformed their non-dividend peers over the long run.
Analysts’ Opinion of MDT
Many brokerage firms have already submitted their reports for MDT stocks, with RBC Capital Mkts repeating the rating for MDT by listing it as a “Outperform.” The predicted price for MDT in the upcoming period, according to RBC Capital Mkts is $105 based on the research report published on October 10, 2024 of the current year 2024.
Oppenheimer, on the other hand, stated in their research note that they expect to see MDT reach a price target of $94, previously predicting the price at $92. The rating they have provided for MDT stocks is “Perform” according to the report published on August 21st, 2024.
UBS gave a rating of “Neutral” to MDT, setting the target price at $90 in the report published on August 15th of the current year.
MDT Trading at -4.81% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.41% of loss for the given period.
Volatility was left at 1.60%, however, over the last 30 days, the volatility rate increased by 1.24%, as shares sank -4.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.00% lower at present.
During the last 5 trading sessions, MDT fell by -2.98%, which changed the moving average for the period of 200-days by -2.00% in comparison to the 20-day moving average, which settled at $85.98. In addition, Medtronic Plc saw 1.92% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDT starting from PARKHILL KAREN L, who proposed sale 30,000 shares at the price of $89.73 back on Oct 31 ’24. After this action, PARKHILL KAREN L now owns shares of Medtronic Plc, valued at $2,691,794 using the latest closing price.
PARKHILL KAREN L, the Former Director of Medtronic Plc, proposed sale 15,000 shares at $90.58 during a trade that took place back on Oct 30 ’24, which means that PARKHILL KAREN L is holding shares at $1,358,740 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.63 for the gross margin
The net margin for Medtronic Plc stands at 0.13. The total capital return value is set at 0.08. Equity return is now at value 8.58, with 4.76 for asset returns.
Based on Medtronic Plc (MDT), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.58. The interest coverage ratio of the stock is 7.68.
Currently, EBITDA for the company is 8.2 billion with net debt to EBITDA at 2.93. When we switch over and look at the enterprise to sales, we see a ratio of 4.08. The receivables turnover for the company is 5.27for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.84.
Conclusion
To sum up, Medtronic Plc (MDT) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
